- Details
- Description
Packaging Size:
30 capsules
Strength:
100 mg
Composition:
Larotrectinib
Treatment:
Anti-Cancer / Oncology
Form:
Capsule
Brand:
Tractoni 100
Quantity Unit:
Capsules
Manufacturer:
Ziska Pharmaceuticals Limited
Tractoni 100 (Larotrectinib) is an oral targeted anti-cancer medicine containing larotrectinib, a selective TRK inhibitor that blocks abnormal TRK signaling caused by NTRK gene fusions. It is used to treat certain locally advanced or metastatic solid tumors that have an NTRK gene fusion, particularly when surgery is likely to cause significant complications. Tractoni 100 contains 100 mg of larotrectinib and is listed as an anti-cancer product.
